Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
JAMA|April 14, 2011
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trialChristian Lienhardt, Sharlette V Cook, Marcos Burgos, et al.
Emerging Infectious Diseases|September 21, 2021
Antimicrobial Resistance in Africa-How to Relieve the Burden on Family FarmersChristian Ducrot, Alexandre Hobeika, Christian Lienhardt, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The Journal of Infectious Diseases|April 10, 2004
Interleukin-8 polymorphism is not associated with pulmonary tuberculosis in the gambiaGraham S Cooke, Sarah J Campbell, Katherine Fielding, et al.
Nature Communications|June 8, 2019
Introducing risk inequality metrics in tuberculosis policy developmentM Gabriela M Gomes, Juliane F Oliveira, Adelmo Bertolde, et al.
Infection and Immunity|December 23, 2003
Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test designJohan Vekemans, Martin O C Ota, Jackson Sillah, et al.
The European Respiratory Journal|February 17, 2012
Childhood tuberculosis: progress requires an advocacy strategy nowAndreas Sandgren, Luis E Cuevas, Masoud Dara, et al.
The European Respiratory Journal|August 25, 2018
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical diseaseSandra V Kik, Samuel Schumacher, Daniela Maria Cirillo, et al.
Plos One|January 17, 2008
Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progressionFarba Karam, Fatou Mbow, Helen Fletcher, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
JAMA|April 14, 2011
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trialChristian Lienhardt, Sharlette V Cook, Marcos Burgos, et al.
Emerging Infectious Diseases|September 21, 2021
Antimicrobial Resistance in Africa-How to Relieve the Burden on Family FarmersChristian Ducrot, Alexandre Hobeika, Christian Lienhardt, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The Journal of Infectious Diseases|April 10, 2004
Interleukin-8 polymorphism is not associated with pulmonary tuberculosis in the gambiaGraham S Cooke, Sarah J Campbell, Katherine Fielding, et al.
Nature Communications|June 8, 2019
Introducing risk inequality metrics in tuberculosis policy developmentM Gabriela M Gomes, Juliane F Oliveira, Adelmo Bertolde, et al.
Infection and Immunity|December 23, 2003
Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test designJohan Vekemans, Martin O C Ota, Jackson Sillah, et al.
The European Respiratory Journal|February 17, 2012
Childhood tuberculosis: progress requires an advocacy strategy nowAndreas Sandgren, Luis E Cuevas, Masoud Dara, et al.
The European Respiratory Journal|August 25, 2018
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical diseaseSandra V Kik, Samuel Schumacher, Daniela Maria Cirillo, et al.
Plos One|January 17, 2008
Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progressionFarba Karam, Fatou Mbow, Helen Fletcher, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 12